The abstract is read at the publisher; the summary is JClub's.
A translational human blood-based thrombus platform reproduces patient-derived biphasic stroke clot architecture linked to rtPA resistance, including a compact fibrin shell and neutrophil extracellular trap–stabilized core.
- Why it matters: Recanalization failure after ischemic stroke is driven in part by spatial heterogeneity in cerebral thrombi that existing experimental models do not reproduce well, limiting therapy evaluation.
- What they did: The platform generated reproducible thrombi with alternating red blood cell-rich and platelet-rich territories, then used multiscale structural/biochemical analyses and functional thrombolysis assays to test rtPA lysis susceptibility.
- The result: Breaching the outer fibrin shell in halved thrombi significantly accelerated early rtPA-mediated lysis, while platelet-rich clots with dense plasminogen activator inhibitor-1 and neutrophil extracellular trap networks resisted standard rtPA and were overcome by tenecteplase and adjunctive DNAse.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.